AVI-4126 Injection (RESTEN-NG®)
AVI-4126-21a
Phase 1 small_molecule completed
Quick answer
AVI-4126 Injection (RESTEN-NG®) for Neoplasms is a Phase 1 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed